End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 CAD | -1.41% | -11.39% | -40.68% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-40.68% | 119M | C | ||
+31.96% | 272M | - | ||
+33.74% | 261M | - | ||
+49.42% | 194M | C | ||
+44.98% | 131M | - | ||
-28.57% | 121M | - | - | |
+115.91% | 119M | - | - | |
0.00% | 86.82M | - | - | |
+150.00% | 75.33M | - | - | |
+1.20% | 55.24M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- CBSTF Stock
- CBST Stock
- Ratings The Cannabist Company Holdings Inc.